Immix Biopharma (IMMX) Other Working Capital Changes (2024 - 2026)
Immix Biopharma (IMMX) reported Other Working Capital Changes of -$35229.0 for Q1 2026, down 122.59% on a YoY basis from $155963.5 in Q1 2025, and down 5.57% sequentially from -$33371.0 in Q4 2025.
Immix Biopharma (IMMX) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 3 years of Other Working Capital Changes data on file, last reported at -$35229.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 122.59% year-over-year to -$35229.0; the trailing twelve-month figure through Mar 2026 stood at -$117408.0 (down 242.45% YoY), and the FY2025 full-year result was -$98006.0, down 3536.4% from the prior year.
- Other Working Capital Changes slipped to -$35229.0 in Q1 2026, from -$33371.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q2 2023 to a low of -$1.0 million in Q4 2023.
- A 5-year average of $69279.9 and a median of $20418.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes sank 1450.4% in 2025 and slumped 122.59% in 2026, its largest moves.
- Tracing IMMX's Other Working Capital Changes over 3 years: stood at -$14285.0 in 2024, then slumped by 133.61% to -$33371.0 in 2025, then dropped by 5.57% to -$35229.0 in 2026.
- Business Quant data shows IMMX's Other Working Capital Changes at -$35229.0 in Q1 2026, -$33371.0 in Q4 2025, and -$32667.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immix Biopharma | 487.25 Mn | 487.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,229.00 |
| Mar 31, 2026 | -35,229.00 |
| Mar 31, 2026 | -35,229.00 |
| Dec 31, 2025 | -33,371.00 |
| Dec 31, 2025 | -33,371.00 |
| Dec 31, 2025 | -33,371.00 |
| Sep 30, 2025 | -32,667.00 |
| Sep 30, 2025 | -32,667.00 |
| Sep 30, 2025 | -32,667.00 |
| Jun 30, 2025 | -16,141.00 |
| Jun 30, 2025 | -16,141.00 |
| Jun 30, 2025 | -16,141.00 |
| Mar 31, 2025 | -15,827.00 |
| Mar 31, 2025 | -15,827.00 |
| Mar 31, 2025 | -15,827.00 |
| Dec 31, 2024 | -14,285.00 |
| Dec 31, 2024 | -14,285.00 |
| Dec 31, 2024 | -14,285.00 |
| Sep 30, 2024 | -2,107.00 |
| Sep 30, 2024 | -2,107.00 |